LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The Senate is poised to vote this week on President Donald Trump's rescissions package requesting roughly $9.4 billion in ...

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

DUMAGUETE CITY, Negros Oriental (PIA) — Amid the rising number of Human Immunodeficiency Virus (HIV) cases in the province, ...

The Trump administration agreed to exempt a global AIDS-relief program from spending cuts in the rescissions package.

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

Lenacapavir, which was approved by the United States' Food and Drug Administration in June this year, is taken twice per year ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

The future of the global HIV response risks being undermined by shrinking funding and wavering political will, health leaders have warned as the International AIDS Society (IAS) Conference on HIV ...

The Ghana HIV and AIDS Network (GHANET) is taking a proactive and strategic approach to combat the nation's HIV epidemic, focusing on a demographic often overlooked in health-seeking behaviours.